CALGARY, AB, Feb. 2, 2022 /CNW/ - Universal Ibogaine Inc. (TSXV: IBO) ("UI" or the "Company") a life sciences company with a mission to deliver medicalized ibogaine-centered addiction treatment, has initiated development plans at its Kelburn treatment facility in preparation for treatment protocol approval and commencement of ibogaine treatments. What is Ibogaine? Ibogaine is a plant derived neuroactive compound that appears to reset [...]

Calgary, AB – January 26, 2022 – Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”) a lifesciences company with a mission to develop and deliver medicalized ibogaine-centered addiction care, ispleased to advise it has entered into an agreement (the “agreement”) with Psygen Labs Inc. (“Psygen”)to secure a supply of GMP ibogaine for use in its planned future clinical trial for [...]

Calgary, AB – January 14, 2022 – Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”) a life sciences company with a mission to develop and deliver medicalized ibogaine-centered addiction care, is pleased to introduce its contract research organization (“CRO”) partners who will enable UI’s planned clinical trial in Canada to be conducted, subject to the required approval by Health Canada. [...]

Calgary, AB - TheNewswire - January 10, 2022 - Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”) announces that Rami Batal has been replaced as Chief Executive Officer (“CEO”) of the Company and its subsidiaries.  For the present time, the Company has appointed Nick Karos as CEO, effective immediately.  Mr. Karos had recently been appointed as a Capital Markets consultant to the Company. [...]

Calgary, AB - TheNewswire – December 2, 2021 – Universal Ibogaine Inc. (TSXV:IBO) (“ UI ” or the “ Company ”), a life sciences company with a mission to research and deliver medicalized ibogaine-centered addiction care, is pleased to announce an expansion of its’ Executive team, and welcomes Nick Karos as its new Director – Capital Markets. Mr. Karos is based in Los Angeles, USA, and [...]